Table 1.
All patients N = 198 |
ITT TAU N = 53 |
ITT ST N = 58 |
ITT ST + P N = 61 |
ITT N = 172 pa |
ART TAU N = 83 |
ART ST N = 42 |
ART ST + P N = 44 |
ART N = 169 pa |
|
---|---|---|---|---|---|---|---|---|---|
Age at referral (mean, s.d.) | 21.3 (2.9) | 21.3 (3.3) | 21.7 (2.9) | 21.2 (2.6) | 0.566 | 21.4 (3.1) | 21.5 (2.9) | 21.3 (2.6) | 0.978 |
Male (n;%) | 162 (82%) | 41 (77%) | 48 (83%) | 52 (84%) | 0.639 | 63 (76%) | 36 (86%) | 39 (87%) | 0.227 |
Caucasian (n;%) | 137 (71%) | 37 (70%) | 46 (79%) | 41 (66%) | 0.260 | 60 (72%) | 30 (71%) | 33 (73%) | 0.980 |
Secondary school finished (n;%) | 105 (53%) | 29 (55%) | 30 (52%) | 38 (61%) | 0.557 | 44 (53%) | 22 (52%) | 28 (62%) | 0.551 |
Strauss Carpenter prognostic scale (mean, s.d.) | 39.7 (10.8) | 42.5 (10.3) | 38.2 (10.2) | 40.7 (11.8) | 0.111 | 41.2 (10.0) | 38.3 (10.5) | 40.9 (12.8) | 0.357 |
Premorbid adjustments scale (mean, s.d.) | 14.5 (6.1) | 15.4 (6.4) | 14.5 (5.9) | 14.2 (5.8) | 0.541 | 15.0 (6.1) | 14.7 (6.1) | 13.6 (5.8) | 0.442 |
Duration untreated psychosis 1 year or longer (n; %) | 59 (30%) | 13 (25%) | 18 (31%) | 19 (31%) | 0.700 | 22 (27%) | 12 (29%) | 15 (33%) | 0.717 |
Type of onset (n;%) | |||||||||
Acute | 23 (12%) | 6 (11%) | 5 ( 9 %) | 11 (18%) | 0.137 | 11 (13%) | 3 ( 7%) | 8 (18%) | 0.227 |
Subacute | 70 (35%) | 22 (42%) | 15 (26%) | 23 (37%) | 29 (35%) | 11 (26%) | 18 (41%) | ||
Insidious | 104 (53%) | 25 (47%) | 38 (65%) | 27 (45%) | 43 (52%) | 28 (67%) | 18 (41%) | ||
Onset before age 18 (n;%) | 60 (30%) | 16 (30%) | 13 (22%) | 20 (32%) | 0.458 | 22 (27%) | 12 (29%) | 14 (31%) | 0.857 |
PANSS positive symptoms score (mean s.d.) | 20.7 (7.6) | 20.6 (7.5) | 19.7 (7.8) | 21.4 (7.2) | 0.494 | 21.0 (7.7) | 19.0 (7.4) | 21.2 (7.1) | 0.282 |
PANSS negative symptoms score (mean s.d.) | 21.5 (7.2) | 21.7 (6.0) | 21.4 (6.5) | 21.2 (7.9) | 0.946 | 22.5 (6.6) | 21.4 (6.6) | 20.1 (7.2) | 0.156 |
PANSS general psychopathology symptoms score (mean s.d.) | 40.7 (10.7) | 39.4 (8.6) | 40.7 (12.0) | 40.2 (10.6) | 0.823 | 41.3 (9.5) | 39.0 (12.1) | 39.6 (10.7) | 0.444 |
Voluntary admission (n; %) | 181 (94%) | 51 (96%) | 55 (95%) | 59 (95%) | 0.936 | 78 (94%) | 40 (95%) | 44 (98%) | 0.625 |
Non-remission at start outpatient phase (n; %) | 19 (10%) | 7 (12%) | 6 (9%) | 6 (9%) | 0.853b | 11 (12%) | 3 ( 7%) | 4 ( 8%) | 0.593b |
p = probability in significance test, i.e. analysis of variance or χ2 according to level of measurement.
All variables (except the variable ‘non-remission at start outpatient phase’) were tested twice, including and excluding those who where in non-remission chronic at discharge. Not one test yielded significant differences between conditions. Only tests excluding patients with non-remission are reported, except the test for non-remission itself for obvious reasons.